PMID: 8853211Jul 1, 1996Paper

Polysomnographic effects of hypnotic drugs. A review

L Parrino, M G Terzano


This review aims at providing a critical assessment of the effects of the most widely used benzodiazepine (flurazepam, flunitrazepam, temazepam, triazolam) and non-benzodiazepine (zopiclone and zolpidem) hypnotic drugs, based on the recording of polysomnographic variables. In the light of newly acquired neurophysiological data on the microstructure of sleep, this paper reconsiders the problem of insomnia and the current ideas on polysomnography and hypnotic drugs.


Jan 1, 1975·International Pharmacopsychiatry·J M Gaillard, R Tissot
May 1, 1976·Clinical Pharmacology and Therapeutics·A KalesJ D Kales
Jan 1, 1979·Archives of General Psychiatry·I FeinbergJ D March
Jan 1, 1979·British Journal of Clinical Pharmacology·M MitlerW C Dement
Jan 1, 1979·Pharmacology·M B ScharfC R Soldatos
Oct 1, 1978·Electroencephalography and Clinical Neurophysiology·M W ChurchD M Seales
Sep 1, 1979·Electroencephalography and Clinical Neurophysiology·L C JohnsonM Sinclair
Jan 1, 1975·Psychopharmacologia·G VogelK Sexton
Sep 1, 1975·Clinical Pharmacology and Therapeutics·A KalesM B Scharf
Sep 15, 1978·Science·A KalesJ D Kales
Dec 1, 1992·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·G RosadiniF Ferrillo
Jul 1, 1990·Electroencephalography and Clinical Neurophysiology·M G TerzanoH Depoortere
Mar 19, 1991·European Journal of Pharmacology·A A Borbély, P Achermann
Jun 1, 1990·Journal of Clinical Psychopharmacology·James K WalshM J Muehlbach
Jun 1, 1990·Journal of Clinical Pharmacology·M MamelakV Price
May 1, 1988·Electroencephalography and Clinical Neurophysiology·M G TerzanoM C Spaggiari
Jan 1, 1989·European Journal of Clinical Pharmacology·J M Monti
May 1, 1989·Neurophysiologie clinique = Clinical neurophysiology·M BilliardJ Cadilhac
May 1, 1988·Psychological Medicine·S GolombokM Lader
Jan 1, 1987·Psychopharmacology·L C JohnsonA G Muzet
Sep 1, 1988·Neurophysiologie clinique = Clinical neurophysiology·M G TerzanoJ P Sauvanet
Jan 1, 1988·Journal of Clinical Pharmacology·D J McClureJ C Pecknold
Mar 1, 1988·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J A FlemingP Hamilton
Jan 1, 1988·Developmental and Comparative Immunology·J LecetaA Tejero
Aug 1, 1986·British Journal of Clinical Pharmacology·T RoehrsT Roth
Feb 1, 1986·British Journal of Clinical Pharmacology·A N Nicholson, P A Pascoe
Jan 1, 1980·Psychopharmacology·C OguraW M Wardell
Nov 1, 1980·British Journal of Clinical Pharmacology·A N NicholsonP A Pascoe
Jan 1, 1981·European Journal of Clinical Pharmacology·W Lehmann, B Liljenberg
Apr 22, 1983·European Journal of Pharmacology·A A BorbélyD Lehmann
Jun 1, 1984·British Journal of Clinical Pharmacology·T RoehrsT Roth
Jul 1, 1981·Electroencephalography and Clinical Neurophysiology·L C Johnson, C L Spinweber
Jun 1, 1983·Electroencephalography and Clinical Neurophysiology·L C JohnsonW C Dement
Jan 1, 1983·Pharmacology·M MamelakV Price
Mar 1, 1984·The American Journal of Psychiatry·T L TanE O Bixler
Nov 1, 1982·Archives of Gerontology and Geriatrics·S Hoyer
Jan 1, 1981·Psychopharmacology·I KaracanD Kay
Jul 1, 1982·Journal of Clinical Pharmacology·T RoehrsT Roth
Jan 1, 1982·International Pharmacopsychiatry·U J Jovanovic, J F Dreyfus
Jan 1, 1995·Sleep·M ReiteW Mendelson
Jun 1, 1994·Journal of Veterinary Pharmacology and Therapeutics·L P JagerA J Baars
Jan 1, 1994·European Journal of Clinical Pharmacology·A N VgontzasD C Myers
Feb 1, 1994·Psychological Medicine·P R TataR R Jacobson
Oct 1, 1993·Physiology & Behavior·M G Terzano, L Parrino
Mar 1, 1996·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·M G TerzanoG Di Giovanni
Jun 26, 2001·Psychiatry and Clinical Neurosciences·T HoriSleep Computing Committee of the Japanese Society of Sleep Research Society
Aug 1, 1956·Electroencephalography and Clinical Neurophysiology·M ROTHJ GREEN


Nov 26, 2011·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·S Happe
Feb 9, 2005·Psychopharmacology·Kazuaki ShinomiyaChiaki Kamei
Dec 21, 2000·Current Treatment Options in Neurology·C M MorinMarie-Christine Ouellet
Mar 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P Denise, M L Bocca
Mar 28, 2002·Neurophysiologie clinique = Clinical neurophysiology·P HalaszL Parrino
Sep 2, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·M G TerzanoA Smerieri
Dec 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stefan MathiasM Lancel
Sep 9, 2008·The Australian and New Zealand Journal of Psychiatry·Amanda WheelerElizabeth Robinson
Oct 28, 2009·Brain : a Journal of Neurology·Yaroslau ComptaMaria J Marti
May 12, 2006·International Clinical Psychopharmacology·Saskia van LiemptHerman G M Westenberg
Apr 30, 2005·The Australian and New Zealand Journal of Psychiatry·Richard J KeunemanDavid J Castle
Apr 27, 2000·Acta Psychiatrica Scandinavica·J van OsS G Thompson
Jan 1, 2010·Journal of Oncology·N Sithranga Boopathy, K Kathiresan
Sep 14, 2010·BMC Musculoskeletal Disorders·Piedad Morillas-ArquesElena P Calandre
May 3, 2005·Biological & Pharmaceutical Bulletin·Kazuaki ShinomiyaChiaki Kamei
Aug 17, 2002·Drugs & Aging·Udo WortelboerEckart Rüther
May 31, 2007·Clinical Drug Investigation·E Estivillmembers of the Consensus Group (see page 382)
May 30, 2014·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Cornelius EngelmannHenrik Rüffert
Oct 17, 2014·Expert Review of Clinical Pharmacology·Laura H JacobsonDaniel Hoyer
Apr 30, 2010·Expert Opinion on Pharmacotherapy·Mia ZaharnaC Guilleminault
Mar 10, 2016·The Journal of Head Trauma Rehabilitation·Erin M HolcombRisa Nakase-Richardson
Mar 3, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·M SuetsugiYoshifumi Watanabe
Mar 27, 2007·Pharmacology, Biochemistry, and Behavior·Qing-Ping ChuYong-He Zhang
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Raffaele ManniL Parrino
Mar 5, 2004·Journal of Sleep Research·P HalaszRóbert Bódizs
Jul 13, 2004·Brain Research Bulletin·L ParrinoM G Terzano
Dec 1, 2007·Archives of Physical Medicine and Rehabilitation·Marie-Christine Ouellet, C M Morin
Feb 9, 2007·Journal of Pharmacological Sciences·Shin TokunagaChiaki Kamei
Feb 26, 2008·Pharmacology, Biochemistry, and Behavior·Stephanie C Licata, James K Rowlett
Jul 27, 2001·The Journal of International Medical Research·S Tsutsui, Zolipidem Study Group
Jan 26, 2005·Neurorehabilitation and Neural Repair·Marie-Christine OuelletC M Morin
Apr 30, 1999·Journal of Psychopharmacology·G DarcourtJ Lavoisy
Mar 16, 2018·The Cochrane Database of Systematic Reviews·Lone BaandrupBirte Y Glenthøj
Mar 24, 2004·Journal of Pharmacological Sciences·Hideaki NoguchiToshiharu Shiba
Dec 7, 2007·International Journal of Geriatric Psychiatry·Jur-Shan ChengYaw-Tang Shih
Nov 27, 2019·Journal of Clinical Medicine·Lenise Jihe KimVsevolod Y Polotsky
Mar 1, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M G TerzanoL Parrino
Apr 19, 2003·Comprehensive Therapy·Steven LippmannOxana Matsenko
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Savard, C M Morin
Feb 10, 2000·Journal of Psychopharmacology·T Roth
Jul 12, 2017·Neuropharmacology·Arathi RadhakrishnanKamalesh K Gulia

Related Concepts

Zolpidem AbZ
Zopiclon von ct
Transient Insomnia
Anti-Anxiety Effect

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.